Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
2.795
+0.235 (9.18%)
Nov 9, 2026, 4:00 PM EST - Market closed
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $121.72 million as of November 9, 2026. It is the 24,177th most valuable company in the world and the 3,980th biggest in the United States. Its market cap has increased by 55.59% in one year.
Market Cap
121.72M
Enterprise Value
125.38M
1-Year Change
55.59%
Global Rank
Country Rank
#3,980 United States
Category
ChartMarket Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $121.72M, a decrease of -90.87%. That is a compound annual growth rate of -32.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 121.72M | 33.53% |
| Dec 31, 2025 | 91.16M | -66.00% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inogen | 157.64M |
| Quanterix | 137.15M |
| MaxCyte | 128.49M |
| Apyx Medical | 122.58M |
| Owlet | 121.85M |
| Perspective Therapeutics | 95.89M |
| Sera Prognostics | 84.03M |
| Nyxoah | 83.86M |